Phagocytosis of rat alveolar macrophages (AM) was en hanced by the infusion of arginine-rich solution for 7 days. The enhance ment of phagocytosis by arginine-rich solution was due to not the differ ence in the distribution of AM subpopulations (I to IV) but the difference in phagocytic activity of AM in fraction IV. In the process of phagocy tosis, there were no significant differences in the stages of migration, attachment, and digestion between control and arginine-rich solutions, although AM from fraction IV of rats infused with arginine-rich solution showed significantly higher ingestion of opsonized sheep red blood cells (SRBC) compared to that of control group. Furthermore, the production of macrophage-activating factor (MAF) from rat splenocytes was higher in arginine-rich group than that of control group. AM from fraction IV of rats fed a stock diet had a higher arginase activity and showed a significant increase of Phagocytosis following in vitro incubation with L-arginine (25 and 50mM) for 24h. From these results, the enhanced phagocytosis of AM by arginine-rich solution may be due to the increased phagocytosis of AM from fraction IV, in which the higher sensitivity of AM from fraction IV to arginine and the higher production of MAF from splenocytes following the infusion of arginine-rich solution participate. Key Words arginine, phagocytosis, alveolar macrophages, macrophage activating factor, rats There have been many reports using arginine in a variety of experimental tumors (1, 2) and most of the reports describe favorable results in inhibitions of tumor growth and tumor induction by carcinogens. We have also reported that infusion of an arginine-rich (5%) solution suppresses the growth of tumor at early stage after inoculation and prevents metastases to the liver and kidney (3). Fur thermore, we have found that the inhibitory effect of arginine-rich solution on tumor growth is, in part, due to the activation of immune system such as T cell and macrophage functions by arginine (4). Barbul et al. have also reported that 1%
oral arginine supplements enhance thymic immune functions in healthy and injured animals (5) . In healthy humans, they found that oral arginine supplements (30g/kg B. W.) markedly increased blastogenesis of peripheral blood lymphocytes in re sponse to mitogens (6) . We have also reported that arginine-rich solution can enhance phagocytosis of AM against opsonized SRBC in rats (3) . However, there are not so many reports on the effect of arginine on macrophage functions. Furthermore, in the view of phagocytosis of AM, the exact mechanism of arginine to enhance their functon is not clear. Recently, Oghiso have found that there are morphological and functional heterogeneity among AM in rats (7). Sakai et al. have also separated AM into four subpopulations by discontinuous Percoll gradient centrifugation and found that phagocytosis is greater in AM from high density fractons than those from the lower ones (8) . The enhanced phagocytosis of AM by arginine-rich solution may be due to the increased percent of AM from higher density fractions.
In this study, we examined the effect of arginine-rich solution on the numerical and functional changes of subpopulations of AM in rats and describe the possible mechanism of AM phagocytosis enhanced by arginine-rich solution.
EXPERIMENTAL METHODS
Animals. Specific pathogen-free, inbred F344 male rats, weighting 170 to 190 g, were obtained from Japan SLC, Inc. (Shizuoka). Animals were acclimatized for 1 week to our laboratory coditions before starting the experiment. During this period, they were given stock diet (Oriental Yeast Co., Tokyo). Both control and arginine-rich infusion groups consisted of 10 rats, respectively. In this paper, the representative data from three experiments are shown in each figure.
Surgical operation. Rats were anesthetized with Nembutal (Abbott Labora tories, North Chicago, IL) and a silicon rubber catheter (Dow Corning Corp., Midland, MI) was inserted into the right atrium of the heart through the right jugular vein, and an exit from the back of the neck was sutured subcutaneously. The catheterized rat was placed in an individual metabolic cage and connected to continuous infusion pump (Tokyo Rikakikai Co., Tokyo). At the first day, they were infused a half of daily volume, and then they received infusion solution at a rate of 270ml/kg body weight per day for 7 days.
Compositions of infusion solution. As shown in Table 1 , control and arginine rich solutions were prepared to be isoenergetic and the content of total amino acids in arginine-rich solution was equal to that of control solution. Concentrations of arginine were 0.43% (w/v) in control solution and 1.67% (w/v) in arginine-rich solution.
Plasma amino acid concentrations. At the end of the infusion period, rats were anesthetized with Nembutal and 90min after stopping infusion, venous blood was taken from the inferior vena cava. Main organs were removed and weighed. Amino acid concentrations in the plasma were measured by an automated amino urea the method of Ratner (12) was used in this experiment. Macrophage-activating factor (MAF). MAF production from splenocytes of rats infused with control or arginine-rich solution for 7 days was measured. As an index of MAF activity, the increased rate of phagocytosis of AM from rats fed a stock diet was used in this experiment (9) .
Statistical analysis. The data were analyzed by Student's t-test and differences associated with p values <0.05 were regarded as statistically significant.
RESULTS
Body and organ weights and numbers of splenocytes, thymocytes, and alveolar macrophages (AM)
There was no significant difference in body weight gain for 7 days between the two infusion groups. The weights of organs such as thymus and spleen were also not significantly different between both infusion groups. The numbers of thymo cytes, splenocytes, and AM of rats infused arginine-rich solution were also similar to those of control group. The rats of both infusion groups showed a positive nitrogen balance during the infusion period (data no shown).
Concentrations of amino acids in plasma
As shown in Fig. 1 , the concentrations of Arg, Orn, Cit. Gin, Glu, and lie in plasma of rats infused with arginine-rich solution were significantly higher than those of rats infused with control solution. On the other hand, the concentrations and arginine-rich () solutions for 7 days. * p<0.05, ** p<0.01. Arginase activity in fractionated AM Arginase activity was higher in higher density fractions (III and IV) compared to those of lower density fractions (I and II), but the difference between both 
DISCUSSION
The body weight gain of F344 rats infused with arginine-rich solution was similar to that of control group during the experiment. The weights of immune organs such as thymus and spleen were also not significantly different between both infusion groups. Mizunuma et al. (13) have shown that i.p, injection of excess arginine (500mg/100g B. W.) produces marked necrosis in the pancreas. In this experiment, arginine-rich solution containing four times concentration of arginine compared to that of control solution was intravenously administered for 7 days. The results of body weight gain and organ weights have suggested that arginine-rich solution used in this experiment did not have a toxic effect. Furthermore, it is well known that arginine has an ability to stimulate urea cycle (14, 15) . As shown in Fig. 1 , the concentrations of Orn and Cit in plasma were significantly higher in rats infused with arginine-rich solution compared to those of control group. These findings strongly suggest that urea cycle is stimulated by the infusion of arginine rich solution.
Regarding arginine and immune functions, there are many reports on lympho cyte functions such as mitogenesis (16, 17) , allograft rejection (18) , and delayed hypersensitivity (19) . On the other hand, there were not so many studies on arginine supplementation and macrophage functions. We have found that arginine-rich solution suppresses tumor growth at an early stage of experimental period and the suppressive effect of arginine is associated with the increased function of macrophages (3, 4) . Chandler et al. (20) have found that there are some sub popuplations with morphological and functional differences in AM. Oghiso (7) has also indicated the difference of immunological functions in AM from fractions isolated by centrifugation on density gradients. In general, AM from higher density fractions (III and IV) have higher phagocytic activity compared to that of AM from lower density fractions (I and II) (8) . The enhanced phagocytosis of AM by the infusion of arginine-rich solution may be due to the increased number of AM in higher density fractions. As shown in Fig. 2 , there was not significant difference in the distribution of AM subpopulations between both infusion groups. However, the phagocytic activity of AM from fraction IV was significantly higher in rats infused with arginine-rich solution than that of AM from the same fraction of rats infused with contol solution (Fig. 3) . This suggests that the enhanced phagocytosis of AM following the infusion of arginine-rich solution is due to not increased proportion of AM from higher density fractions but the increased phagocytosis of AM from fraction IV.
Although it is not clear why AM from fraction IV are specifically activated by arginine, there exist several explanations: 1) As shown in Fig. 7 , splenocytes from rats infused with arginine-rich solution for 7 days showed a higher production of MAF without any stimulations. This MAF appears to activate AM and produce a higher phagocytosis of AM. In particular, AM from fraction IV may have a higher sensitivity to MAF compared to those of AM from other fractions. 2) AM from fraction IV of rats fed a stock diet have a higher arginase activity in all fractions. This indicates that AM from fraction IV have a higher ability to metabolize arginine compared to AM from other fractions. This may be associated with the high phagocytosis of AM following the infusion of arginine-rich solution. In fact, AM from fraction IV of rats fed a stock diet showed a higher phagocytic activity following in vitro incubation with L-arginine for 24h as shown in Fig. 8 .
Stossel (21) has suggested that the process of phagocytosis consists of four stages such as migration, attachment, ingestion, and digestion. In this experiment, we investigated on the effect of arginine-rich solution on each stage of phagocytosis of AM from all fractions. As shown in Fig. 4 , there was no significant difference in migration of AM in all fractions between both infusion groups. As to the stage of digestion, AM from fraction III of rats infused arginine-rich solution showed significantly lower activity of cathepsin B compared to that of AM in the same fracton of rats infused with control solution (Fig. 6) . Since it is known that AM from higher density fractions are more immature than those of lower density fraction (8) , the maturation process of AM appears to ensue from fraction IV to fraction I. As shown in Fig. 3 , AM from fraction IV had a higher phagocytic activity in rats infused with arginine-rich solution. In the transition of AM from fraction IV to III, lyososomal enzymes including cathepsin B may be used for treatment of materials phagocytosed within AM. This may be a reason why AM from fraction III of rats infused with arginine-rich solution showed a lower activity of cathepsin B as shown in Fig. 6 . Although there were no significant differences in the stages of migration and digestion of AM from fraction IV between both infusion groups, AM from fraction IV of rats infused with arginine-rich solution showed a higher ingestion of opsonized SRBC compared to those from the same fraction of rats infused with control solution. This result suggests that arginine specifically enhances the stage of ingestion in the process of phagocytosis by AM.
As shown in Fig. 8 , arginine directly activates phagocytosis of AM. Albina et al. have found that arginine is not only metabolized in macrophages but also modulates those macrophage functions by comparing the experimental condition with or without arginine (22) . Although the action of arginine to phagocytosis of AM is unknown, it has been recently shown that the concentration of intracellular ionized calcium ([Ca2+]i) is an important mediator for phagocytosis and acts as a second messenger for phagocytosis (23) . We have found that [ Ca2+]i in AM gradually increases following in vitro incubation with L-arginine (unpublished data). As a result of the increase of [Ca2+]i in AM following the infusion of arginine-rich solution, phagocytosis of AM, especially in fraction IV, may be enhanced in this experiment. The further experiment needs to clarify this hypoth esis.
In summary, our present study has shown that arginine-rich solution specifical ly enhances phagocytosis of AM from fraction IV and its effect is due to the increased ingestion stage in the process of phagocytosis by AM.
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